BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9440818)

  • 1. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.
    Wada M; Uchida H; Ikeda M; Tsunekawa B; Naito N; Banba S; Tanaka E; Hashimoto Y; Honjo M
    Mol Endocrinol; 1998 Jan; 12(1):146-56. PubMed ID: 9440818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
    Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
    Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms.
    Ikeda M; Wada M; Fujita Y; Takahashi S; Maekawa K; Honjo M
    Growth Horm IGF Res; 2000 Oct; 10(5):248-55. PubMed ID: 11042021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
    Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
    Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
    J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
    Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
    Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization.
    Uchida H; Banba S; Wada M; Matsumoto K; Ikeda M; Naito N; Tanaka E; Honjo M
    J Mol Endocrinol; 1999 Dec; 23(3):347-53. PubMed ID: 10601980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA.
    Wada M; Ikeda M; Takahashi Y; Asada N; Chang KT; Takahashi M; Honjo M
    Mol Cell Endocrinol; 1997 Oct; 133(2):99-107. PubMed ID: 9406855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone.
    Hashimoto Y; Ikeda I; Ikeda M; Takahashi Y; Hosaka M; Uchida H; Kono N; Fukui H; Makino T; Honjo M
    J Immunol Methods; 1998 Dec; 221(1-2):77-85. PubMed ID: 9894899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH.
    Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):317-22. PubMed ID: 9920101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical trial of 20K-hGH.
    Hayakawa M; Shimazaki Y; Tsushima T; Kato Y; Takano K; Chihara K; Shimatsu A; Irie M
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1562-71. PubMed ID: 15070913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
    Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
    Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20K hGH.
    Asada N; Takahashi Y; Wada M; Naito N; Uchida H; Ikeda M; Honjo M
    Mol Cell Endocrinol; 2000 Apr; 162(1-2):121-9. PubMed ID: 10854705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone.
    Wu Z; Devany E; Balarini G; Junnila R; Bidlingmaier M; Strasburger CJ
    Growth Horm IGF Res; 2010 Jun; 20(3):239-44. PubMed ID: 20304691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors.
    Baumann G; Lowman HB; Mercado M; Wells JA
    J Clin Endocrinol Metab; 1994 May; 78(5):1113-8. PubMed ID: 8175967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel specific bioassay for serum human growth hormone.
    Ishikawa M; Nimura A; Horikawa R; Katsumata N; Arisaka O; Wada M; Honjo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4274-9. PubMed ID: 11095467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20K is bound with high affinity by one rat and one of two rabbit growth hormone receptors.
    Hughes JP; Tokuhiro E; Simpson JS; Friesen HG
    Endocrinology; 1983 Nov; 113(5):1904-6. PubMed ID: 6313333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.